CV Guidance For Diabetes Drugs Will Stick: An Interview With FDA’s Mary Parks
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency’s head of metabolism and endocrinology products makes sense of new data on glycemic control, addresses Avandia flak.